CN Bio Innovations (formerly known as Zyoxel) is a company that develops organ-on-a-chip systems for human drug discovery and preclinical research. It provides a platform for generating human-relevant efficacy, ADME (Absorption, Distribution, Metabolism, Excretion), and safety data.